Epidemiological studies conducted on patients suffering from migraine, inflammatory bowel disease, and asthma showed an increased risk of developing the so-called complex regional pain syndrome (CRPS) in the limbs owing to the destruction of nerve fibers [54]
221 The addition of L-citrulline (a precursor of the L-arginine cycle and NO synthesis) to medications in obese asthmatic patients may assist in asthma control and improve fractional NO excretion (FeNO) levels
GH, IGF-I and insulin used as PED Growth Hormone The emergence of GH as a PED began sometime before 1985 when the first description of its purported effects and recommendations for performance enhancement was published (Duchaine, 1982)
The prices are going down, Lilly and NovoNordisk have expanded their direct-to-consumer marketing and seem to have reduced their efforts to litigate against compounding pharmacies that supply compounded GLP-1s
May 29 Product: Tris Pharmas Onyda XR Indication: Attention deficit hyperactivity disorder Wednesday, the FDA greenlit Tris Pharmas Onyda XR as the first non-stimulant medication for attention deficit hyperactivity disorder (ADHD) with a liquid formulation and nighttime dosing, according to the company
For people with type 2 diabetes who found semaglutide insufficient for blood sugar control or weight management, these numbers offer concrete evidence that tirzepatide provides a meaningful upgrade